Breckin L. Forstrom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Breckin L. Forstrom has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Aaron Rappleyea
Department of Chemical and Biological Engineering, Department of Life Sciences, Brigham Young University, Provo, UT 84602, USA
1 shared publication - Alexander D. Daum
Department of Chemistry, University of Utah, Salt Lake City, UT, 84112 – United States of America
1 shared publication - Bowen J. Houser
Department of Chemical and Biological Engineering, Department of Life Sciences, Brigham Young University, Provo, UT 84602, USA
1 shared publication - Jacob B. Limburg
Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA
1 shared publication - Joseph P. Talley
Department of Chemical Engineering, Brigham Young University, Provo, UT 84602, USA
1 shared publication - Karine Chesnel
Brigham Young University
1 shared publication
Latest Publications
- Open Access
- 29 August 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (38) , 31402-31415
Magnetic nanoparticles tethered with Zn–DPA for the removal of bacteria from red blood cell suspension
Bacterial infections continue to drive the need for more effective and rapid methods for bacterial analysis. To address this, magnetic nanoparticles (MNPs) have emerged as promising tools, especially when their surfaces are modified with bacteria binders. The bis-zinc–dipicolylamine (Zn–DPA) complex is known for its broad affinity to bacteria. We have synthesized MNPs via a thermal decomposition method, encapsulated them in silica, modified their surface with Zn–DPA, and tested their ability to remove bacteria. The MNPs retain their superparamagnetic properties and crystallite structure after being encapsulated. The MNPs coated with silica and Zn–DPA effectively bind and remove both Gram-positive and Gram-negative bacteria from bacterial suspensions in both PBS buffer and red blood cell suspension. The capture efficiency (CE) of bacteria is high, >0.95 for both concentrated (1 × 108 CFU) and dilute (1 × 103 CFU) suspensions of Gram-positive and Gram-negative bacteria in PBS. The bacterial capture efficiency in red blood cell suspension with 50% hematocrit ranges is high (CE > 0.95) for both concentrated and dilute suspensions of S. aureus but lower for concentrated (CE = 0.30) and dilute (CE = 0.15) suspensions of E. coli. The Zn–DPA coated MNPs have promising binding efficiencies for a broad-spectrum of bacteria within a short period of time, potentially leading to applications in diagnostic devices for both medical and industrial uses.
- 29 August 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (38) , 31402-31415
Open AccessMagnetic nanoparticles tethered with Zn–DPA for the removal of bacteria from red blood cell suspension
Bacterial infections continue to drive the need for more effective and rapid methods for bacterial analysis. To address this, magnetic nanoparticles (MNPs) have emerged as promising tools, especially when their surfaces are modified with bacteria binders. The bis-zinc–dipicolylamine (Zn–DPA) complex is known for its broad affinity to bacteria. We have synthesized MNPs via a thermal decomposition method, encapsulated them in silica, modified their surface with Zn–DPA, and tested their ability to remove bacteria. The MNPs retain their superparamagnetic properties and crystallite structure after being encapsulated. The MNPs coated with silica and Zn–DPA effectively bind and remove both Gram-positive and Gram-negative bacteria from bacterial suspensions in both PBS buffer and red blood cell suspension. The capture efficiency (CE) of bacteria is high, >0.95 for both concentrated (1 × 108 CFU) and dilute (1 × 103 CFU) suspensions of Gram-positive and Gram-negative bacteria in PBS. The bacterial capture efficiency in red blood cell suspension with 50% hematocrit ranges is high (CE > 0.95) for both concentrated and dilute suspensions of S. aureus but lower for concentrated (CE = 0.30) and dilute (CE = 0.15) suspensions of E. coli. The Zn–DPA coated MNPs have promising binding efficiencies for a broad-spectrum of bacteria within a short period of time, potentially leading to applications in diagnostic devices for both medical and industrial uses.